nivolumab,ipilimumab
ono Pharmaceuticals,BMS,ono Pharmaceuticals,BMS
['colorectal', 'breast', 'rectal', 'natera', '$ntra ']
$ntra natera presents new colorectal and breast cancer data at esmo 2022, highlighting signatera's ability to inform treatment decisions in the adjuvant and neoadjuvant settings 
This is an automated account sharing new press releases in real time from https://t.co/7iCFuj68H6